Skip to content

Author

Xiao-Yu Han

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Meta-analysis Open access Sep 2026

Overall survival with immune checkpoint inhibitors across treatment settings and clinical and PD-L1-defined subgroups in advanced esophageal squamous cell carcinoma: a systematic review and meta-analysis of randomized trials

ICI-containing regimens improved overall survival in both first- and later-line settings, but aggregate within-trial interaction analyses did not identify a reliable clinical or PD-L1-defined treatment-effect modifier.

Bing Wang, Xiao-Yu Han, Zeng-Li Shen · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.